Nucleation and crystal growth in supersaturated solutions of a model drug.

The crystallization process in aqueous solutions of the drug bicalutamide and the effect of the polymer polyvinylpyrrolidone (PVP) have been studied. Results showed that PVP decreased the crystallization rate significantly in a system with PVP concentrations as low as 0.01% (w/w), without changing the polymorph formed. The crystal habit was altered already at PVP concentrations as low as 0.001% (w/w). Measurements made with self-diffusion NMR indicated that the decrease in crystallization rate was not because of a reduced supersaturation due to bicalutamide binding to PVP in solution. Furthermore, in experiments designed to specifically study crystal nucleation, the same nucleation rate was found in the absence and presence of PVP. Instead, PVP adsorbs to the crystals formed in solution and by doing so, the crystal growth rate is reduced. This was confirmed in separate experiments using bicalutamide nanocrystals. By combining theories describing classical nucleation and crystal growth, with some modifications, a consistent description of several independent experiments performed in polymer-free systems was obtained. From these experiments a crystal-water interfacial tension of 22.1 mN/m was extracted. We also analyze the interfacial tension of other crystalline organic solids and find that it varies approximately as the logarithm of the solubility. This finding is discussed within the framework of the Bragg-Williams regular solution theory where we also compare with the tension of liquid alkanes.

[1]  P. Vekilov,et al.  Are Nucleation Kinetics of Protein Crystals Similar to Those of Liquid Droplets , 2000 .

[2]  Ulf Norinder,et al.  Global and Local Computational Models for Aqueous Solubility Prediction of Drug-Like Molecules , 2004, J. Chem. Inf. Model..

[3]  Ulf Olsson,et al.  Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[4]  D. Grant,et al.  The effect of structurally related substances on the nucleation kinetics of paracetamol (acetaminophen) , 1995 .

[5]  P. Vekilov,et al.  Direct Determination of the Nucleation Rates of Protein Crystals , 1999 .

[6]  Charles F. Zukoski,et al.  Nanoparticle Crystal Nucleation: Influence of Solution Conditions , 2002 .

[7]  I. Leubner.  Crystal formation (nucleation) under kinetically-controlled and diffusion-controlled growth conditions , 1987 .

[8]  P. Williams,et al.  Adsorption of Polyvinylpyrrolidone onto Polystyrene Latices and the Effect on Colloid Stability , 1996 .

[9]  J Hadgraft,et al.  Crystallization of hydrocortisone acetate: influence of polymers. , 2001, International journal of pharmaceutics.

[10]  K. Wilson,et al.  Anisotropic surface energetics and wettability of macroscopic form I paracetamol crystals. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[11]  H. Rupprecht,et al.  CONTROL OF CRYSTAL GROWTH IN DRUG SUSPENSIONS. PART 1:DESIGN OF A CONTROL UNIT AND APPLICATION TO ACETAMINOPHEN SUSPENSIONS , 1988 .

[12]  M. Mintun,et al.  Dissolution kinetics of phenylbutazone. , 1981, Journal of pharmaceutical sciences.

[13]  P. Vekilov,et al.  Nucleation of Protein Crystals: Critical Nuclei, Phase Behavior, and Control Pathways , 2001 .

[14]  A. Adamson.  Physical chemistry of surfaces , 1960 .

[15]  G. Wegner,et al.  Polymers designed to control nucleation and growth of inorganic crystals from aqueous media. , 2001 .

[16]  Griselda Polla,et al.  Conformational polymorphism in bicalutamide. , 2007, International journal of pharmaceutics.

[17]  Ulf Olsson,et al.  Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[18]  U. Olsson,et al.  Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[19]  Oleg Galkin,et al.  On the Methods of Determination of Homogeneous Nucleation Rates of Protein Crystals , 2003 .

[20]  Dimo Kashchiev,et al.  Nucleation : basic theory with applications , 2000 .

[21]  Åke C. Rasmuson,et al.  Primary nucleation of paracetamol in acetone-water mixtures , 2001 .

[22]  O. Söhnel,et al.  Interfacial surface tension for crystallization and precipitation from aqueous solutions , 1990 .

[23]  Kenji Nishimura,et al.  Inhibitory effects of water-soluble polymers on precipitation of RS-8359 , 1997 .

[24]  Yi Li,et al.  Prediction of aqueous solubility of organic compounds using a quantitative structure-property relationship. , 2002, Journal of pharmaceutical sciences.

[25]  Allan S. Myerson,et al.  A statistical understanding of nucleation , 1999 .

[26]  B. Jönsson.  Surfactants and Polymers in Aqueous Solution , 1998 .

[27]  W L Jorgensen,et al.  Prediction of drug solubility from Monte Carlo simulations. , 2000, Bioorganic & medicinal chemistry letters.

[28]  Ulf Norinder,et al.  Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility , 2002, Pharmaceutical Research.

[29]  J. Newton,et al.  Assessment of the wettability of powders by use of compressed powder discs , 1986 .

[30]  W. Higuchi,et al.  Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone. , 1970, Journal of pharmaceutical sciences.

[31]  Xiang‐Yang Liu.  Interfacial Effect of Molecules on Nucleation Kinetics , 2001 .

[32]  Dongqing Li,et al.  Contact angles on hydrophobic solid surfaces and their interpretation , 1992 .

[33]  J. Fell,et al.  Contact angle determinations on pharmaceutical powders: A comparison of two methods , 1979 .